Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

95 trials with published results (29%)

Research Maturity

244 completed trials (75% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.1%

20 terminated out of 326 trials

Success Rate

92.4%

+5.9% vs benchmark

Late-Stage Pipeline

18%

59 trials in Phase 3/4

Results Transparency

39%

95 of 244 completed with results

Key Signals

95 with results92% success20 terminated

Data Visualizations

Phase Distribution

253Total
Not Applicable (112)
Early P 1 (3)
P 1 (44)
P 2 (35)
P 3 (25)
P 4 (34)

Trial Status

Completed244
Recruiting21
Terminated20
Unknown18
Active Not Recruiting8
Withdrawn7

Trial Success Rate

92.4%

Benchmark: 86.5%

Based on 244 completed trials

Clinical Trials (326)

Showing 20 of 20 trials
NCT03839212Not ApplicableCompletedPrimary

The Happy Older Latinos Are Active (HOLA) Health Promotion Study in HIV-Infected Latino Men

NCT03823209Not ApplicableCompletedPrimary

Increasing PrEP Use in High-Risk Social Networks of African-American MSM in Underserved Low-Risk Cities

NCT03729778Early Phase 1Active Not Recruiting

Impact of HIV-1 and Aging on Mucosal Vaccine Responses

NCT03300830RecruitingPrimary

Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease

NCT05404750Active Not RecruitingPrimary

Harm Reduction in HIV Primary Care for PLWH Who Use Drugs

NCT06176859Not ApplicableCompleted

Delivery Optimization for Pre-Exposure Prophylaxis (DO PrEP) Study

NCT06819176Phase 1RecruitingPrimary

Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretroviral Therapy

NCT02344680CompletedPrimary

Liver Fibrosis in Zambian HIV-HBV Co-infected Patients

NCT07101458Not ApplicableActive Not RecruitingPrimary

The Eswatini PRISM Study on Adolescents Living With HIV

NCT03690063RecruitingPrimary

Nice Human Immunodeficiency Virus (HIV) Cohort

NCT04704336Not ApplicableCompletedPrimary

Integration of Hypertension Management Into HIV Care in Nigeria

NCT02479698Phase 2Recruiting

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

NCT05231707Not ApplicableCompletedPrimary

Simunye: A Couples-focused Intervention for HIV Prevention and Care in South Africa

NCT06139224Not ApplicableRecruiting

Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection

NCT05385484Not ApplicableActive Not RecruitingPrimary

A Savings Intervention to Reduce Men's Engagement in HIV Risk Behaviors

NCT03190317CompletedPrimary

Health Information for Infected Veterans

NCT03254277Phase 1CompletedPrimary

3BNC117-LS First-in-Human Phase 1 Study

NCT06519994Phase 2CompletedPrimary

Feasibility of Intravaginal Artesunate as Adjuvant HPV & Cervical Precancer Treatment in Kenya

NCT06233331Phase 1Not Yet Recruiting

Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV

NCT05933226Not ApplicableActive Not RecruitingPrimary

Project Khanya: Peer-Delivered Intervention to Improve HIV Medication Adherence and Substance Use in South Africa

Scroll to load more

Research Network

Activity Timeline